Reuters logo
5 months ago
BRIEF-Brainstorm Cell Therapuetics signs MoU with Tel Aviv Sourasky Medical Center
March 1, 2017 / 12:04 PM / 5 months ago

BRIEF-Brainstorm Cell Therapuetics signs MoU with Tel Aviv Sourasky Medical Center

1 Min Read

March 1 (Reuters) - Brainstorm Cell Therapuetics Inc

* Brainstorm Cell Therapuetics-signed MOU with medical research, infrastructure, and health services fund of Tel Aviv Sourasky Medical Center

* Brainstorm Cell Therapuetics Inc- agreement is expected to be formalized in first half of 2017

* Brainstorm Cell Therapuetics - MOU also covers participation of Tel Aviv Sourasky Medical Center in planned phase 3 trial that will investigate nurown in ALS

* Brainstorm Cell- MOU to explore possibility of making nurown available to als patients under provisions of hospital exemption regulation

* Brainstorm cell - mou sets forth terms under which co, tel aviv sourasky medical center would work to submit application to israeli ministry of health

* Brainstorm cell therapuetics - signed mou to explore possibility of making nurown available to als patients under hospital exemption regulation Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below